HUE071118T2 - Piperidinil-indol származékok C3 glomerulopátia kezelésében történõ alkalmazásra - Google Patents

Piperidinil-indol származékok C3 glomerulopátia kezelésében történõ alkalmazásra

Info

Publication number
HUE071118T2
HUE071118T2 HUE18769510A HUE18769510A HUE071118T2 HU E071118 T2 HUE071118 T2 HU E071118T2 HU E18769510 A HUE18769510 A HU E18769510A HU E18769510 A HUE18769510 A HU E18769510A HU E071118 T2 HUE071118 T2 HU E071118T2
Authority
HU
Hungary
Prior art keywords
glomerulopathy
treatment
indole derivatives
piperidinyl
piperidinyl indole
Prior art date
Application number
HUE18769510A
Other languages
English (en)
Hungarian (hu)
Inventor
Joerg Eder
Richard Alexander Harrison
Boerje Haraldsson
Anna Svenja Schubart
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of HUE071118T2 publication Critical patent/HUE071118T2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HUE18769510A 2017-08-31 2018-08-30 Piperidinil-indol származékok C3 glomerulopátia kezelésében történõ alkalmazásra HUE071118T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP17188870 2017-08-31

Publications (1)

Publication Number Publication Date
HUE071118T2 true HUE071118T2 (hu) 2025-08-28

Family

ID=59745840

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE18769510A HUE071118T2 (hu) 2017-08-31 2018-08-30 Piperidinil-indol származékok C3 glomerulopátia kezelésében történõ alkalmazásra

Country Status (22)

Country Link
US (3) US11723901B2 (da)
EP (3) EP4393545B1 (da)
JP (3) JP6754919B1 (da)
KR (3) KR102682887B1 (da)
CN (5) CN117398384A (da)
AU (1) AU2018326768B2 (da)
BR (1) BR112020003737A2 (da)
CA (1) CA3073346A1 (da)
CL (1) CL2020000483A1 (da)
DK (2) DK3675854T3 (da)
ES (2) ES3022885T3 (da)
FI (2) FI3675854T3 (da)
HR (2) HRP20250386T1 (da)
HU (1) HUE071118T2 (da)
IL (1) IL272888B2 (da)
LT (2) LT4393545T (da)
MX (3) MX2020002185A (da)
PL (2) PL4393545T3 (da)
PT (2) PT4393545T (da)
RS (2) RS66635B1 (da)
SI (2) SI4393545T1 (da)
WO (1) WO2019043609A1 (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112020003737A2 (pt) 2017-08-31 2020-09-01 Novartis Ag usos de derivados de piperidinil-indol
WO2021125313A1 (ja) * 2019-12-19 2021-06-24 大鵬薬品工業株式会社 縮合ピリミジン化合物を有効成分とする治療剤
KR20250048392A (ko) 2020-05-18 2025-04-08 노파르티스 아게 Lnp023의 결정질 형태
US20230286947A1 (en) * 2020-08-07 2023-09-14 Shanghai Meiyue Biotech Development Co. Ltd Complement factor b inhibitor, and pharmaceutical composition, preparation method and use thereof
US20230331710A1 (en) * 2020-08-07 2023-10-19 Shanghai Meiyue Biotech Development Co. Ltd Heterocyclic compound, preparation method and use thereof
CN119798256A (zh) * 2020-12-30 2025-04-11 江苏恒瑞医药股份有限公司 含氮桥杂环化合物、其制备方法及其在医药上的应用
JP7641388B2 (ja) * 2020-12-30 2025-03-06 エス－インフィニティ ファーマシューティカルズ カンパニー リミテッド 一連のピペリジン置換安息香酸系化合物及びその使用
JP2024517234A (ja) * 2021-05-07 2024-04-19 ノバルティス アーゲー 非典型溶血性尿毒症症候群の処置のためのイプタコパン
CA3229360A1 (en) * 2021-08-18 2023-02-23 Chen Zhang Benzo nitrogen-containing heteroaromatic ring derivative and use thereof in medicine
EP4423076A4 (en) * 2021-10-27 2026-01-07 Hansoh Bio Llc PIPERIDINYL INDOLE DERIVATIVES, THEIR PREPARATION PROCESSES AND MEDICAL USES
CR20240300A (es) * 2022-01-24 2024-08-23 Novartis Ag Derivados espirocíclicos de piperidinilo como inhibidores del factor b del complemento y usos de los mismos.
EP4471021A4 (en) * 2022-01-26 2025-04-30 Shanghai Meiyue Biotech Development Co., Ltd. Salt type and crystal form of complement factor b inhibitor, and preparation method therefor and application thereof
CN119343347A (zh) * 2022-06-10 2025-01-21 正大天晴药业集团股份有限公司 双环取代的芳香羧酸酯类化合物
WO2023246677A1 (zh) * 2022-06-20 2023-12-28 深圳信立泰药业股份有限公司 一种吲哚-苯基哌啶化合物及其制备方法与应用
US20250382287A1 (en) 2022-06-30 2025-12-18 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Pharmaceutically acceptable salt and crystal form of nitrogen-containing bridge heterocyclic derivative, and method for preparing same
CN117327070A (zh) * 2022-06-30 2024-01-02 江苏恒瑞医药股份有限公司 一种含氮桥杂环衍生物的晶型及其制备方法
JP2025530222A (ja) * 2022-09-10 2025-09-11 江▲蘇▼豪森▲薬▼▲業▼集▲団▼有限公司 ２－置換ピペリジン誘導体、その製造方法及び医薬的用途
EP4617266A1 (en) 2022-11-11 2025-09-17 Shanghai Yisheng Biopharmaceutical company Limited Piperidine-substituted benzoic acid compound, and pharmaceutical composition and use thereof
WO2024141011A1 (zh) * 2022-12-31 2024-07-04 深圳晶泰科技有限公司 补体因子b抑制剂及其药物组合物和应用
TWI896250B (zh) * 2023-07-26 2025-09-01 大陸商上海美悦生物科技發展有限公司 螺環烯基類或氮雜烯基類化合物及其藥物組合物、製備方法和用途
WO2026086939A1 (zh) * 2024-10-25 2026-04-30 上海美悦生物科技发展有限公司 杂环化合物在制备预防或治疗IgA肾病的药物中的用途
WO2026093943A1 (en) 2024-10-31 2026-05-07 Novartis Ag Chemical process for preparing phenylpiperidinyl indole derivatives

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8192742B2 (en) * 2007-03-23 2012-06-05 NovelMed Therapeutics Method of inhibiting complement activation with human anti-factor C3 antibodies and use thereof
ES2712190T3 (es) 2012-06-28 2019-05-09 Novartis Ag Moduladores de la vía del complemento y sus usos
CN105229003B (zh) * 2013-03-14 2017-03-15 诺华股份有限公司 作为补体因子b抑制剂用于治疗眼科疾病的2‑(1h‑吲哚‑4‑基甲基)‑3h‑咪唑并[4,5‑b]吡啶‑6‑甲腈衍生物
JO3425B1 (ar) * 2013-07-15 2019-10-20 Novartis Ag مشتقات البابيريدينيل-اندول واستخدامها كعامل متمم لمثبطات b
AU2016375183B2 (en) * 2015-12-23 2021-01-21 eleva GmbH Polypeptides for inhibiting complement activation
SG11201805695SA (en) * 2016-01-05 2018-07-30 Univ Leicester Methods for inhibiting fibrosis in a subject in need thereof
BR112020003737A2 (pt) 2017-08-31 2020-09-01 Novartis Ag usos de derivados de piperidinil-indol
KR20250048392A (ko) 2020-05-18 2025-04-08 노파르티스 아게 Lnp023의 결정질 형태
US11951101B2 (en) 2020-07-16 2024-04-09 Novartis Ag Methods of using factor B inhibitors

Also Published As

Publication number Publication date
US20220152011A1 (en) 2022-05-19
EP4647121A2 (en) 2025-11-12
FI3675854T3 (fi) 2025-04-07
PT3675854T (pt) 2025-04-04
EP3675854B1 (en) 2025-01-22
WO2019043609A1 (en) 2019-03-07
HRP20250386T1 (hr) 2025-05-23
JP6754919B1 (ja) 2020-09-16
JP2020529466A (ja) 2020-10-08
LT3675854T (lt) 2025-04-25
RU2020111788A3 (da) 2021-12-28
EP4393545A3 (en) 2024-09-25
US12285422B2 (en) 2025-04-29
KR102682887B1 (ko) 2024-07-08
RS67530B1 (sr) 2026-01-30
KR20200047540A (ko) 2020-05-07
CN111032042A (zh) 2020-04-17
EP4647121A3 (en) 2026-02-18
JP6929425B2 (ja) 2021-09-01
ES3022885T3 (en) 2025-05-29
EP4393545A2 (en) 2024-07-03
RS66635B1 (sr) 2025-04-30
DK3675854T3 (da) 2025-04-07
DK4393545T3 (da) 2026-01-12
AU2018326768A1 (en) 2020-02-06
IL272888A (en) 2020-04-30
SI4393545T1 (sl) 2026-02-27
KR20240111007A (ko) 2024-07-16
US20200338059A1 (en) 2020-10-29
MX2023010750A (es) 2023-09-20
ES3058507T3 (en) 2026-03-11
MX2023010751A (es) 2023-09-20
BR112020003737A2 (pt) 2020-09-01
PL4393545T3 (pl) 2026-03-16
IL272888B1 (en) 2023-09-01
KR102497487B1 (ko) 2023-02-08
EP3675854A1 (en) 2020-07-08
CN117338782A (zh) 2024-01-05
CN117338781A (zh) 2024-01-05
FI4393545T3 (fi) 2026-01-14
CN117398384A (zh) 2024-01-16
CA3073346A1 (en) 2019-03-07
US20250195493A1 (en) 2025-06-19
PT4393545T (pt) 2025-12-23
CL2020000483A1 (es) 2020-09-04
HRP20251596T1 (hr) 2026-01-30
SI3675854T1 (sl) 2025-05-30
LT4393545T (lt) 2026-01-12
RU2020111788A (ru) 2021-09-30
IL272888B2 (en) 2024-01-01
AU2018326768B2 (en) 2021-07-29
EP4393545B1 (en) 2025-10-08
CN117338783A (zh) 2024-01-05
PL3675854T3 (pl) 2025-05-19
KR20230024432A (ko) 2023-02-20
JP2020193222A (ja) 2020-12-03
US11723901B2 (en) 2023-08-15
JP7297016B2 (ja) 2023-06-23
MX2020002185A (es) 2020-07-14
JP2021181471A (ja) 2021-11-25

Similar Documents

Publication Publication Date Title
DK3675854T3 (da) Piperidinyl-indolderivativer til anvendelse ved behandling af c3-glomerulopati
FR24C1036I2 (fr) Derives de piperidinyl indole et leur utilisation en tant qu'inhibiteurs de complement factor b
PL3660004T3 (pl) Związki i sposoby do ukierunkowanej degradacji receptora androgenowego
SI3110418T1 (sl) Arilne, heteroarilne in heterociklične spojine za zdravljenje s komplementom posredovanih motenj
HUE052099T2 (hu) Indol származékok felhasználásra az orvostudományban
IL247841A0 (en) Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders
LT3472153T (lt) Pirimidin-2-ilamino-1h-pirazolai kaip lrrk2 inhibitoriai, skirti naudoti neurodegeneracinių sutrikimų gydyme
LT3206497T (lt) Kompozicijos ir būdai, skirti meibomo liaukos disfunkcijos gydymui
DK3663292T3 (da) Diphenylmethan-derivat i krystallinsk form
EP3402486C0 (en) CCX168 FOR USE IN THE TREATMENT OF C3 GLOMERULOPATHY
IL261948B (en) Transduced indulin derivatives as inhibitors of dengue virus replication
LT2961410T (lt) Pirazolopirimidino darinių naudojimas gydant su pi3k susijusius sutrikimus
EP3227271C0 (en) HETEROCYCLIC DERIVATIVES AND THEIR USE
IL261943A (en) Transformed indulin derivatives as inhibitors of dengue virus replication
MA41794A (fr) Agents thérapeutiques modifiés et compositions associées
LT3200815T (lt) Būdai ir kompozicijos, skirti vėžio gydymui
DK3102200T3 (da) Terapeutisk forbindelse og sammensætning
HRP20190432T1 (hr) Spojevi pladienolid piridina i postupci uporabe
DK3164123T3 (da) Hidtil ukendte anvendelser af benzylidenguanidinderivater til behandling af proteopatier
IL251904B (en) Apilimod for use in the treatment of melanoma
PL3236960T3 (pl) Fluralaner do zastosowania w leczeniu demodekozy
DK3371168T3 (da) Indolin-2-on-derivater
PL3194421T3 (pl) Związki cytotoksyczne i przeciwmitotyczne oraz sposoby ich wykorzystania
LT3601296T (lt) 2-okso-tiazolo derivatai kaip a2a inhibitoriai ir junginiai, skirti naudoti gydant vėžį
DK2968479T3 (da) Terapeutiske sure ceramidasesammensætninger og fremgangsmåder til fremstilling og anvendelse heraf